gray market glp 1 Glucagon-like peptide-1 (GLP-1) injectable medications have shown a lot of promise for managing chronic conditions like diabetes and obesity. But their popularity and price has spurred many lookalikes that are not GLP-1s Novo Nordisk sees pills capturing

Description

After seven days, roughly 38% of the previous dose remains, compared to about 50% for semaglutide

Biochem Biophys Res Commun 2020;530:37480

In collaboration with Steno Diabetes Center, we also plan to analyze blood samples from patients who have either received GLP-1-based treatment or undergone bariatric surgery, to see whether one of these approaches has a stronger effect on inflammation more broadly

MeAgain helps by keeping meals, water, protein, the weekly shot, and custom notes in one place instead of scattering them across a food app, a notes app, and your memory

The more cautious interpretation is that patients who receive GLP-1 receptor agonists may differ in important but incompletely measured ways from those treated with insulin or metformin, including overall health, treatment access, healthcare follow-up, or cardiometabolic care intensity